Scrambler therapy

Scrambler Therapy Clinical Information: Pain Management Center at Tor-Vergata University Medical Center (PTV)

Basic Principles

The basic research leading to the development of Scrambler Therapy applies instead a cybernetic-type analysis in a regime of particularly complex system conditions identified as the phase in which the nociceptive stimulus is translated into a sequence of biopotentials that actually bring about the pain information. The assumption is that the chronicization of the damage modifies the pain system by reorganizing the nervous network response as a function of the dominant algic information and not only of tissue damage with a consequent increase in information entropy. The same mechanism of variation of the emerging properties of the nervous processing network is thus used in reverse in Scrambler Therapy by using artificial neurons to synthesize the information sequences which stimulate endogenous biopotentials and thus reducing the entropy of the information. Previous studies showed how dermatometric transmission of the pain-antagonizing synthetic information is perceived as self, thereby deceiving the nervous system, which responds immediately through the absence of pain at the time of application regardless of its initial intensity.

The technology is from the research of Professor Giuseppe Marineo, a researcher and bioengineer, and the founder and manager of Delta Research & Development. Delta R&D, formed in May 1998, is a Medical Bioengineering Research Centre affiliated with Tor Vergata University of Rome in Italy.

Main Menu

See Also

Main Menu